Cocrystal Systems of Pharmaceutical Interest: 2009

Profiles of Drug Substances, Excipients and Related Methodology

Volumn 36, Issue , 2011, Pages 361-381

  Brittain, Harry G ^a  

^a Center for Pharmaceutical Physics   (United States)

Author keywords

Cocrystal systems; Mechanochemistry; Pharmaceutical interest; Solvent drop grinding

Indexed keywords

2 NAPHTHOIC ACID DERIVATIVE; 4 AMINOBENZOIC ACID; ACETAMIDE DERIVATIVE; BARBITURIC ACID; BENZAMIDE; BENZOIC ACID; BENZOIC ACID DERIVATIVE; BENZOPHENONE; BENZOTHIAZOLE DERIVATIVE; CAFFEINE; CARBAMAZEPINE; CARBOXYLIC ACID DERIVATIVE; EMBONIC ACID; FUMARIC ACID; GABAPENTIN; GLUTARIC ACID; INDOMETACIN; LAMIVUDINE; LIDOCAINE; MANDELIC ACID; N [4 [[6 [4 (TRIFLUOROMETHYL)PHENYL]PYRIMIDIN 4 YL]OXY]1,3 BENZOTHIAZOL 2 YL]ACETAMIDE; NICOTINAMIDE; OROTIC ACID; PHTHALIC ACID; SQUARIC ACID; SUCCINIC ACID; THEOPHYLLINE; TIOTROPIUM BROMIDE; UNCLASSIFIED DRUG; URACIL 5 CARBOXYLIC ACID; ZIDOVUDINE;

BOOK; CHEMICAL BOND; CHEMICAL INTERACTION; CRYSTAL STRUCTURE; CRYSTALLIZATION; DIMERIZATION; DRUG BIOAVAILABILITY; DRUG SOLUBILITY; DRUG STRUCTURE; MOLECULAR MECHANICS; PARTICLE SIZE; PHARMACEUTICAL ENGINEERING; PRIORITY JOURNAL; SUPRAMOLECULAR CHEMISTRY; X RAY CRYSTALLOGRAPHY;

EID: 79957945424     PISSN: 18715125     EISSN: None     Source Type: Book Series    
DOI: 10.1016/B978-0-12-387667-6.00010-5     Document Type: Chapter

References (71)

1. Aakeröy C.B., Salmon D.J. Building co-crystals with molecular sense and supramolecular sensibility. CrystEngComm 2005, 7:439-448.
2. Vishweshwar P., McMahon J.A., Bis J.A., Zaworotko M.J. Pharmaceutical cocrystals. J. Pharm. Sci. 2006, 95:499-516.
3. Shan N., Zaworotko M.J. The role of cocrystals in pharmaceutical science. Drug Discov. Today 2008, 13:440-446.
4. Desiraju G.R. Supramolecular synthons in crystal engineering: a new organic synthesis. Angew. Chem. Int. Ed. 1995, 34:2311-2327.
5. Zaworotko M.J. Molecules to crystals, crystals to molecules and back again?. Cryst. Growth Des. 2007, 7:4-9.
6. Schultheiss N., Newman A. Pharmaceutical cocrystals and their physicochemical properties. Cryst. Growth Des. 2009, 9:2950-2967.
7. Stahly G.P. A survey of cocrystals reported prior to 2000. Cryst. Growth Des. 2009, 9:4212-4229.
8. Brittain H.G. Cocrystal systems of pharmaceutical interest: 2007-2008. Profiles of Drug Substances, Excipients, and Related Methodology, vol. 35 2010, 373-390. Elsevier Academic Press, Amsterdam. H.G. Brittain (Ed.).
9. Fábián L. Cambridge structural database analysis of molecular complementarity in cocrystals. Cryst. Growth Des. 2009, 9:1436-1443.
10. Eppel S., Bernstein J. Statistics-based design of multicomponent molecular crystals with the three-center hydrogen bond. Cryst. Growth Des. 2009, 9:1683-1691.
11. Chadwick K., Sadiq G., Davey R.J., Seaton C.C., Pritchard R.G., Parkin A. Designing acid-acid cocrystals: the use of Hammett substitution constants. Cryst. Growth Des. 2009, 9:1278-1279.
12. Khan M., Enkelmann V., Brunklaus G. O-H...N Heterosynthon: a robust supramolecular unit for crystal engineering. Cryst. Growth Des. 2009, 9:2354-2362.
13. Rajput L., Biradha K. Design of cocrystals via new and robust supramolecular synthon between carboxylic acid and secondary amide: honeycomb network with jailed aromatics. Cryst. Growth Des. 2009, 9:40-42.
14. Issa N., Karamertzanis P.G., Welch G.W.A., Price S.L. Can the formation of pharmaceutical cocrystals be computationally predicted? I. Comparison of lattice energies. Cryst. Growth Des. 2009, 9:442-453.
15. Ainouz A., Authelin J.-R., Billot P., Lieberman H. Modeling and prediction of cocrystal phase diagrams. Int. J. Pharm. 2009, 374:82-89.
16. Schartman R.R. On the thermodynamics of cocrystal formation. Int. J. Pharm. 2009, 365:77-80.
17. He G., Chow P.S., Tan R.B.H. Predicting multicomponent crystal formation: the interplay between homomeric and heteromeric interactions. Cryst. Growth Des. 2009, 9:4529-4532.
18. ter Horst J.H., Deij M.A., Cains P.W. Discovering new co-crystals. Cryst. Growth Des. 2009, 9:1531-1537.
19. Frisčić T., Jones W. Recent advances in understanding the mechanism of cocrystal formation via grinding. Cryst. Growth Des. 2009, 9:1621-1637.
20. Karki S., Frisčić T., Jones W. Control and interconversion of cocrystal stoichiometry in grinding: stepwise mechanism for the formation of a hydrogen-bonded cocrystal. CrystEngComm 2009, 11:470-481.
21. Frisčić T., Childs S.L., Rizvi S.A.A., Jones W. The role of solvent in mechanochemical and sonochemical cocrystal formation: a solubility-based approach for predicting cocrystallization outcome. CrystEngComm 2009, 11:418-426.
22. Colombo I., Grassi G., Grassi M. Drug mechanochemical activation. J. Pharm. Sci. 2009, 98:3961-3986.
23. Kaupp G. Mechanochemistry: the varied applications of mechanical bond-breaking. CrystEngComm 2009, 11:388-403.
24. Good D.J., Rodríguez-Hornedo N. Solubility advantage of pharmaceutical cocrystals. Cryst. Growth Des. 2009, 9:2252-2264.
25. Bethune S.J., Huang N., Jayasankar A., Rodríguez-Hornedo N. Understanding and predicting the effect of cocrystal components and pH on cocrystal solubility. Cryst. Growth Des. 2009, 9:3976-3988.
26. Aakeröy C.B., Forbes S., Desper J. Using cocrystals to systematically modulate aqueous solubility and melting behavior of an anticancer drug. J. Am. Chem. Soc. 2009, 131:17048-17049.
27. Brittain H.G. Vibrational spectroscopic studies of cocrystals and salts. 1. The benzamide-benzoic acid system. Cryst. Growth Des. 2009, 9:2492-2499.
28. Brittain H.G. Vibrational spectroscopic studies of cocrystals and salts. 2. The benzylamine benzoic acid system. Cryst. Growth Des. 2009, 9:3497-3503.
29. Parrott E.P.J., Zeitler J.A., Frisčić T., Pepper M., Jones W., Day G.M., Gladden L.F. Testing the sensitivity of terahertz spectroscopy to changes in molecular and supramolecular structure: a study of structurally similar cocrystals. Cryst. Growth Des. 2009, 9:1452-1460.
30. Vogt F.G., Clawson J.S., Strohmeier M., Edwards A.J., Pham T.N., Watson S.A. Solid-state NMR analysis of organic cocrystals and complexes. Cryst. Growth Des. 2009, 9:921-937.
31. Childs S.L., Wood P.A., Rodríguez-Hornedo N., Reddy L.S., Hardcastle K.I. Analysis of 50 crystal structures containing carbamazepine using the materials module of mercury CSD. Cryst. Growth Des. 2009, 9:1869-1888.
32. Weyna D.R., Shattock T., Vishweshwar P., Zaworotko M.J. Synthesis and structural characterization of cocrystals and pharmaceutical cocrystals: mechanochemistry vs. slow evaporation from solution. Cryst. Growth Des. 2009, 9:1106-1123.
33. Maheshwari C., Jayasankar A., Khan N.A., Amidon G.E., Rodríguez-Hornedo N. Factors that influence the spontaneous formation of pharmaceutical cocrystals by simply mixing solid reactants. CrystEngComm 2009, 11:493-500.
34. Jayasankar A., Reddy L.S., Bethune S.J., Rodríguez-Hornedo N. Role of cocrystal and solution chemistry on the formation and stability of cocrystals with different stoichiometry. Cryst. Growth Des. 2009, 9:889-897.
35. Chieng N., Hubert M., Saville D., Rades T., Aaltonen J. Formation kinetics and stability of carbamazepine-nicotinamide cocrystals prepared by mechanical activation. Cryst. Growth Des. 2009, 9:2377-2386.
36. Gagniere E., Mangin D., Puel F., Bebon C., Klein J.-P., Monnier O., Garcia E. Cocrystal formation in solution: in situ solute concentration monitoring of the two components and kinetic pathways. Cryst. Growth Des. 2009, 9:3376-3383.
37. Sheikh A.Y., Rahim S.A., Hammond R.B., Roberts K.J. Scalable solution cocrystallization: case of carbamazepine-nicotinamide. CrystEngComm 2009, 11:501-509.
38. Stanton M.K., Tufekcic S., Morgan C., Bak A. Drug substance and former structure property relationships in 15 diverse pharmaceutical co-crystals. Cryst. Growth Des. 2009, 9:1344-1352.
39. Nichol G.S., Clegg W. Classical and weak hydrogen bonding interactions between 4,4'-bipyridine and organic acids: from co-crystal to organic complex. Cryst. Growth Des. 2009, 9:1844-1850.
40. Buar D.-K., Henry R.F., Lou X., Duerst R.W., MacGillivray L.R., Zhang G.G.Z. Cocrystals of caffeine and hydroxybenzoic acids composed of multiple supramolecular heterosynthons: screening via solution-mediated phase transformation and structural characterization. Cryst. Growth Des. 2009, 9:1932-1943.
41. Aitipamula S., Chow P.S., Tan R.B.H. Trimorphs of a pharmaceutical cocrystal involving two active pharmaceutical ingredients: potential relevance to combination drugs. CrystEngComm 2009, 11:1823-1827.
42. Reddy L.S., Bethune S.J., Kampf J.W., Rodríguez-Hornedo N. Cocrystals and salts of gabapentin: pH dependent cocrystal stability and solubility. Cryst. Growth Des. 2009, 9:378-385.
43. Umeda Y., Fukami T., Furuishi T., Suzuki T., Tanjoh K., Tomono K. Characterization of multicomponent crystal formed between indomethacin and lidocaine. Drug Dev. Indust. Pharm. 2009, 35:843-851.
44. Padrela L., Rodrigues M.A., Velaga S.P., Matos H.A., de Azevedo E.G. Formation of indomethacin-saccharin cocrystals using supercritical fluid technology. Eur. J. Pharm. Sci. 2009, 38:9-17.
45. Bhatt P.M., Azim Y., Thakur T.S., Desiraju G.R. Co-crystals of the anti-HIV drugs lamivudine and zidovudine. Cryst. Growth Des. 2009, 9:951-957.
46. Anderson K.M., Probert M.R., Whiteley C.N., Rowland A.M., Goeta A.E., Steed J.W. Designing co-crystals of pharmaceutically relevant compounds that crystallize with Z'>1. Cryst. Growth Des. 2009, 9:1082-1087.
47. Viertelhaus M., Hilfiker R., Blatter F. Piracetam co-crystals with OH-group functionalized carboxylic acids. Cryst. Growth Des. 2009, 9:2220-2228.
48. Aitipamula S., Chow P.S., Tan R.B.H. Theophylline-gentisic acid (1/1). Acta Cryst. 2009, E65:o2126-o2127.
49. Pop M., Sieger P., Cains P.W. Tiotropium fumarate: an interesting pharmaceutical co-crystal. J. Pharm. Sci. 2009, 98:1820-1834.
50. Martins D.M.S., Middlemiss D.S., Pulham C.R., Wilson C.C., Weller M.T., Henry P.F., Shankland N., Shankland K., Marshall W.G., Ibberson R.M., Knight K., Moggach S., Brunelli M., Morrison C.A. Temperature- and pressure-induced proton transfer in the 1:1 adduct formed between squaric acid and 4,4'-bipyridine. J. Am. Chem. Soc. 2009, 131:3884-3893.
51. Seaton C.C., Parkin A., Wilson C.C., Blagden N. Controlling the formation of benzoic acid: isonicotinamide molecular complexes. Cryst. Growth Des. 2009, 9:47-56.
52. Fujii K., Ashida Y., Uekusa H., Hirano S., Toyota S., Toda F., Pan Z., Harris K.D.M. Vapor induced crystalline transformation investigated by ab initio powder X-ray diffraction analysis. Cryst. Growth Des. 2009, 9:1201-1207.
53. Jacobs T., Lloyd G.O., Bredenkamp M.W., Barbour L.J. Co-crystallization of ionic and neutral supramolecular motifs derived from identical components. Cryst. Growth Des. 2009, 9:1284-1286.
54. Sarma B., Nath N.K., Bhogala B.R., Nangia A. Synthon competition and cooperation in molecular salts of hydroxybenzoic acids and aminopyridines. Cryst. Growth Des. 2009, 9:1546-1557.
55. Du M., Zhang Z.-H., Guo W., Fu X.-J. Multi-component hydrogen-bonding assembly of a pharmaceutical agent pamoic acid with piperazine or 4,4'-bipyridyl: a channel hydrated salt with multiple-helical motifs vs a bimolecular cocrystal. Cryst. Growth Des. 2009, 9:1655-1657.
56. Chadwick K., Davey R.J., Dent G., Pritchard R.G. Cocrystallization: a solution chemistry perspective and the case of benzophenone and diphenylamine. Cryst. Growth Des. 2009, 9:1990-1999.
57. Mohamed S., Tocher D.A., Vickers M., Karamertzanis P.G., Price S.L. Salt or cocrystal? A new series of crystal structures formed from simple pyridines and carboxylic acids. Cryst. Growth Des. 2009, 9:2881-2889.
58. Wishkerman S., Bernstein J., Hickey M.B. Crystal engineering with cocrystals of benzo-[18]crown-6 and urea and thiourea derivatives. Cryst. Growth Des. 2009, 9:3204-3210.
59. Tominaga M., Katagiri K., Azumaya I. Pseudopolymorph and charge-transfer co-crystal of disubstituted adamantane containing dimethoxyphenol moieties. Cryst. Growth Des. 2009, 9:3692-3696.
60. Roy S., Mahata G., Biradha K. Cocrystal and salts of 2,2',6,6'-tetracarboxybiphenyl with bis(pyridyl) derivatives: eight-fold interpenetrated diamondoid and layered networks. Cryst. Growth Des. 2009, 9:5006-5008.
61. Basu T., Sparkes H.A., Mondal R. Construction of extended molecular networks with heterosynthons in cocrystals of pyrazole and acids. Cryst. Growth Des. 2009, 9:5164-5175.
62. Chadwick K., Davey R., Sadiq G., Cross W., Pritchard R. The utility of a ternary phase diagram in the discovery of new co-crystal forms. CrystEngComm 2009, 11:412-414.
63. Orola L., Veidis M.V. Nicotinamide fumaric acid supramolecular cocrystals: diversity of stoichiometry. CrystEngComm 2009, 11:415-417.
64. Aakeröy C.B., Salmon D.J., Smith M.M., Desper J. Cyanooximes as effective and selective co-crystallizing agents. CrystEngComm 2009, 11:439-443.
65. Skovsgaard S., Bond A.D. Co-crystallization of benzoic acid derivatives with N-containing bases in solution and by mechanical grinding: stoichiometric variants, polymorphism and twinning. CrystEngComm 2009, 11:444-453.
66. Oswald I.D.H., Crichton W.A. Structural similarities of 2-chlorophenol and 2-methylphenol. CrystEngComm 2009, 11:463-469.
67. Koner R., Goldberg I. Crystal engineering of molecular networks: hydrogen bonding driven two-dimensional assemblies of tetrapyridylporphyrin with benzene tri- and tetra-carboxylic acids. CrystEngComm 2009, 11:1217-1219.
68. Ellis C.A., Miller M.A., Spencer J., Zukerman-Schpector J., Tiekink E.R.T. Cocrystallization experiments of thiocarbamides with bipyridine-type molecules. CrystEngComm 2009, 11:1352-1361.
69. Bacchi A., Carcelli M., Chiodo T., Cantoni G., De Filippo C., Pipolo S. A discussion on the solid state organization of 4-pyridylimino compounds and on the cocrystallization between their molecular precursors. CrystEngComm 2009, 11:1433-1441.
70. Jacobs T., Lloyd G.O., Bredenkamp M.W., Barbour L.J. Breaking the trigonal host packing motif of Dianin's compound. CrystEngComm 2009, 11:1545-1548.
71. Callear S.K., Hursthouse M.B., Threlfall T.L. Cocrystallization of organic α,ω-dicarboxylic acids with the cyclic amides 2-pyrrolidinone and 2-imidazolidinone. CrystEngComm 2009, 11:1609-1614.